Dr. Dave Miller
Vice President of Research and Development,
Dave A. Miller, Ph.D. is the Vice President of Research and Development at DisperSol Technologies. He earned a B.S. in Chemical Engineering and a Ph.D. in Pharmaceutics from the University of Texas at Austin. Prior to joining DisperSol, Dr. Miller held the position of Senior Principal Scientist at Hoffmann-La Roche, Inc. Dr. Miller has published numerous research articles, book chapters, and patent applications in the field of solubility enhancement and is co-editor of the recently published book, Formulating Poorly Water Soluble Drugs.
Director, Formulation Research and Development Advance Delivery Technologies, Catalent Pharma Solutions
Ron Vladyka has over 20 years of experience in pharmaceutical development. His development experience, over his career, has included development of novel delivery systems for parental, inhalation, and oral administration. Ron has been part of the formulation development team at Catalent for over six years. His responsibilities include development and transfer of technologies and oral delivery systems that aid in solubilizing poorly soluble drugs compounds. His other research interests include compaction and multi-particulate modified release systems. He also holds several U.S. Patents in the area of improvement of bioavailability.
Dr. Benjamin Maynor
Ph.D., VP R&D, Liquidia Technologies
Benjamin Maynor, Ph.D. is currently serves as the Vice President, Research at Liquidia Technologies, a nanotechnology company in the Research Triangle Park, NC that focuses on the production of drug delivery systems for ophthalmology, vaccines, and pulmonary therapeutics. As part of his responsibilities he also leads Liquidia’s programs for small molecule/biologic drug delivery. Ben is a co-inventor of Liquidia’s PRINT technology. He joined Liquidia in 2005 and has initiated several new technology initiatives at Liquidia, including programs in ophthalmology, respiratory drug delivery, and other therapeutic areas. He received a Ph.D. in Chemistry from Duke University, where he focused on nanofabrication, nanostructure synthesis and materials chemistry. He also holds a B.A. in Chemistry from Harvard University. He has co-authored over 20 peer-reviewed publications in the fields of nanotechnology, colloid science, and drug delivery and has been a co-inventor on several patents and patent applications in the fields of nanotechnology and drug delivery.
Dr. Ronak Savla
Applied Drug Delivery Fellow,
Rutgers Pharmaceutical Industry Fellowship Program
Ronak Savla is currently the Applied Drug Delivery Fellow with Catalent Pharma Solutions through the Rutgers Pharmaceutical Industry Fellowship Program. Ronak graduated summa cum laude with a Doctor of Pharmacy degree from Rutgers School of Pharmacy and a Ph.D. in Pharmaceutical Sciences from Rutgers University. Ronak has experience working with tumor responsive targeted multifunctional nanosystems for cancer imaging, chemo- and siRNA therapy. Ronak is an author and co-author on over 35 publications including peer-reviewed papers, conference proceedings, and posters.
Dr. Shahar Keinan
Chief Scientific Officer, Cloud Pharmaceuticals
Shahar Keinan has extensive experience in the field of computational and theoretical chemistry. She obtained a Ph.D. in theoretical chemistry and a B.S. in Chemistry from The Hebrew University of Jerusalem, and post-doc in Northwestern and Duke universities. She has published over 25 peer-reviewed research articles.
Senior Research Fellow, department of Drug Product Design of Pharmaceutical Sciences, Pfizer, Inc.
Ravi Shanker is Senior Research Fellow in the department of Drug Product Design of Pharmaceutical Sciences at Pfizer Worldwide Research and Development in Groton CT. Ravi has over 25 years of research experience in the areas of drug delivery, discovery support and biopharmaceutics at Pfizer. He has numerous papers and patents in the field of drug delivery. Ravi has mentored PhD dissertation research for students and taught graduate level courses as an adjunct faculty member. He has collaborated globally with industrial entrepreneurs and academic researchers for enhanced fundamental understanding of drug absorption and delivery. He has been an invited speaker at numerous national and international conferences and is a member of the Editorial Board of Journal of Pharmaceutical Science. Ravi’s current responsibilities include leading a global Biopharmaceutics Group at Pfizer. Ravi received his Bachelors in Pharmacy from Banaras Hindu University in India; Masters and PhD in Pharmaceutical Chemistry from the University of Kansas.
Senior Director, Innovation, West Pharmaceutical Services
Chris has been in new product development for over 25 years, primarily in pharmaceutical & healthcare packaging/device development. His background is in Engineering and Industrial Design, and he holds 19 U.S. patents with a dozen more pending. Chris is responsible for West’s user-centered delivery device design, with a focus on early stage innovation, technology integration, platform feasibility and optimizing the patient experience.